Metabolic Signalling Pathway Research Documentation
Peer-reviewed journal articles and study summaries covering pathway-oriented laboratory investigation of metabolic signalling mechanisms.
BioIntegrity provides peer-reviewed literature and precisely synthesised compounds for advanced laboratory research. Explore our analytical methodology and published references.
Our Liquid Peptide Sprays are formulated with Advanced Ion technology, an ionic liquid excipient platform built from citric acid and the amino acids lysine and arginine — pharmacopoeially established, GRAS-listed components rather than novel synthetic permeation enhancers. The platform is characterised for peptide solubility and membrane partition behaviour through lipid modulation, dual-polarity solubilisation, molecular partition optimisation, and cation exchange. Independent third-party laboratory testing reports room-temperature stability with HPLC recovery inside ICH Q1A(R2) acceptance limits, and non-cytotoxic classification under ISO 10993-5. Laboratory note: formulations on this platform form reversible ionic complexes with the peptide cargo; HPLC quantification at 100x dilution under-reports peptide content, so use 1,000x dilution prior to injection. Characterisation data is available to institutional purchasers on request.
Formulations are developed with a vertically integrated peptide manufacturer overseeing synthesis through final packaging. Released lots are assigned a batch-specific Certificate of Analysis from an independent laboratory, reporting identity by LC-MS and purity by HPLC-UV. Bacterial endotoxin by LAL is reported where that assay was performed. Published results are in the COA library.
Manufactured under cGMP standards, with every released lot assigned a unique lot number that maps to its analytical record on this site. Identity and purity are determined by an independent laboratory, AxisPharm, LLC, and published as permanent records.
Active researchEmpowering discovery
Driven by science
Our supply chain is built around compounds characterised in the published literature and verified analytically before release. Material is produced in GMP-compliant facilities and lots are verified for identity and purity, with the analytical results published on this site as permanent records.
Pathway-level reference topics, organised by the research category each covers. Each links to the compounds it concerns.
Peer-reviewed journal articles and study summaries covering pathway-oriented laboratory investigation of metabolic signalling mechanisms.
Published literature covering GLP-1, GIP and glucagon receptor agonist characterisation, including comparative receptor potency and biased agonism studies.
Study summaries covering NAD⁺ biosynthesis, sirtuin cofactor availability, telomerase expression, and mitochondrial function in cultured systems.
Peer-reviewed literature on GHRH receptor analogues, ghrelin receptor secretagogues, and insulin-like growth factor binding-protein interactions.
Published work on neurotrophic factor expression, dendritic spine density, monoamine turnover, and GABAergic signalling in neural tissue models.
Literature covering hypothalamic-pituitary-gonadal axis signalling, melanocortin receptor subtype selectivity, and neuropeptide receptor binding.
Study summaries on fibroblast migration assays, angiogenic signalling, extracellular matrix organisation, and NF-κB pathway modulation.
Literature summaries are compiled from published, peer-reviewed sources and are provided for reference. Inclusion of a reference is not a claim about any outcome. Current analytical figures for material in stock — every published lot assayed at 99.0% purity or higher, across 51 lots — are in the COA library.